Prevalence of pre-diabetes and associated risk factors in an adult Omani population
- 127 Downloads
The Sultanate of Oman has experienced an epidemiological transition over the last 4 decades with rising tide of non-communicable disease such as type-2 diabetes. This study aims to estimate the prevalence of pre-diabetes and explore the associated demographic, clinical and biochemical risk factors among a semi-urban Omani population. A semi-urban satellite town, Bidbid, located about 30 km west of the capital, Muscat, was selected as the study setting. The targeted participants were Omani adults (18 to 60 years old) who had resided in Bidbid municipality for at least 6 months prior to enrollment in the study. Using multistage random sampling, 1,600 Bidbid residents were invited to participate in the study. The study protocol gathered data on the socio-demographic and clinical backgrounds of the participants. Participants’ impaired glucose tolerance (IGT) impaired fasting glucose (IFG) and cholesterol and triglyceride levels were then measured. The study surveyed 1,313 individuals (490 men and 823 women) out of 1,600 who had been invited to participate. The participation rate was higher among women than men (91.5% compared to 54.3%). A total of 459 individuals (35% of participants) were diagnosed as pre-diabetic by either the IGT or IFG test; 121 (9%) were pre-diabetic by virtue of both measurements. Male gender, advanced age and obesity were each independently associated with higher prevalence of pre-diabetes. Increased prevalence of pre-diabetes also correlated with the indices of hypercholesterolemia and dyslipidaemia. Pre-diabetes is a substantial health problem in Oman that may present a significant challenge to the national healthcare system in the near future. Customized interventions targeting groups with high risk of pre-diabetes, especially men, the elderly and the obese, are urgently needed.
KeywordsDiabetes Pre-diabetes Oman Prevalence Survey
Body mass index
Census enumeration area
Fasting plasma glucose
Impaired fasting glucose
Impaired glucose tolerance
We are grateful to the men and women who volunteered as subjects for this research.
Conflicts of interest
- 3.Shi HL, Fang JC, Zhu XX. Prevalence of diabetes mellitus and associated risk factors in an adult urban population in Shanghai. Diabetes Metabol. 1998;24:539–42.Google Scholar
- 10.Rerkpattanapipat P, D’Agostino Jr RB, Link KM, Shahar E, Lima JA, Bluemke DA, et al. Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the multi-ethnic study of atherosclerosis. Diabetes. 2009;58:946–53.PubMedCrossRefGoogle Scholar
- 14.Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;7:393–403.Google Scholar
- 25.Al-Shereiqi S. Non communicable diseases screening: starts in Oman. Community Health Dis Surveill News (Oman). 2008;17:1–5.Google Scholar
- 26.Nichols GA, Arondekar B, Herman WH. Complications of dysglycemia and medical costs associated with non-diabetic hyperglycemia. Am J Manag Care. 2008;14:791–8.Google Scholar
- 33.World Health Organization. Preventing chronic diseases: a vital investment: WHO global report. Geneva: World Health Organization; 2005.Google Scholar
- 37.Barakat MN, Al-Shereiqi SZ. Operational and management Guidelines for the National non-communicable diseases screening program. Communicable Diseases Surveillance and Control. Directorate General of Health Affairs. Accessed in March 28: 2010 http://www.moh.gov.om/reports/Guidelines_Manual_for_the_national_NCD_screening_program.pdf.